BioSpace

Lilly’s guidance has jumped by $10B as GLP-1 sales keep blowing past expectations

With the commercial business performing so well, Eli Lilly is eyeing earlier business development bets to build out a longer-term pipeline.

By BioSpace

1 min read
Lilly’s guidance has jumped by $10B as GLP-1 sales keep blowing past expectations
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights